Edition:
United States

Medical Equipment, Supplies & Distribution

Page 3

AngioDynamics Says U.S. Tax Reform To Have Impact Of $0.02- $0.04 On Non-GAAP Adjusted EPS In FY 2018

Wednesday, 10 Jan 2018 09:00am EST

Jan 10 (Reuters) - AngioDynamics Inc ::ANGIODYNAMICS SAYS U.S. TAX REFORM ACT TO HAVE AN IMPACT IN RANGE OF $0.02- $0.04 ON NON-GAAP ADJUSTED EPS IN FY 2018 -SEC FILING.

InspireMD Sees Q4 2017 Sales About $833,000

Wednesday, 10 Jan 2018 07:30am EST

Jan 10 (Reuters) - Inspiremd Inc ::SEES Q4 2017 SALES ABOUT $833,000.

Glaukos' Idose Travoprost Achieves Sustained IOP Reduction And Favorable Safety Profile In 12-Month Interim Cohort

Wednesday, 10 Jan 2018 07:00am EST

Jan 10 (Reuters) - Glaukos Corp ::GLAUKOS CORPORATION’S IDOSE™ TRAVOPROST ACHIEVES SUSTAINED IOP REDUCTION AND FAVORABLE SAFETY PROFILE IN 12-MONTH INTERIM COHORT.GLAUKOS CORP - COMPANY PREPARES TO COMMENCE PHASE III U.S. IND STUDY IN FIRST HALF OF 2018.GLAUKOS CORP - COMPANY BEGINS PROCESS FOR IDOSE TRAVOPROST REGULATORY APPROVAL IN EUROPE AND JAPAN.GLAUKOS CORP - CONDUCTED A PRODUCTIVE END-OF-PHASE II MEETING WITH FDA IN LATE 2017.

Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln

Tuesday, 9 Jan 2018 04:15pm EST

Jan 9 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES PRELIMINARY 2017 RESULTS AND PROVIDES 2018 GUIDANCE.SEES FY 2018 SALES $132 MILLION TO $140 MILLION.SEES FY 2018 SALES UP ABOUT 23 TO 32 PERCENT.- PRELIMINARY Q4 ‍GAAP SALES INCREASED TO APPROXIMATELY $39 MILLION TO $40 MILLION FROM $28.9 MILLION IN 2016​.TANDEM DIABETES CARE - EXPECT Q4 PUMP SHIPMENTS INCREASED TO ABOUT 7,000 PUMPS.- 2018 GAAP SALES ARE ESTIMATED TO BE IN RANGE OF $132 MILLION TO $140 MILLION.FY2018 REVENUE VIEW $133.6 MILLION -- THOMSON REUTERS I/B/E/S.

Globus Medical Expects Q4 Sales Of About $175.5 mln

Tuesday, 9 Jan 2018 09:45am EST

Jan 9 (Reuters) - Globus Medical Inc ::GLOBUS MEDICAL REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR SALES RESULTS.EXPECTS Q4 SALES OF ABOUT $175.5 MILLION.SEES Q4 2017 SALES ABOUT $175.5 MILLION.SEES FY 2018 FULLY DILUTED NON-GAAP EARNINGS PER SHARE OF $1.50.SEES FY 2018 SALES $690 MILLION.TO REINVEST PORTION OF ANTICIPATED SAVINGS FROM U.S. TAX REFORM BY INCREASING SPENDING ON EMERGING TECHNOLOGIES BY ABOUT $14 MILLION IN 2018.

Globus Medical sees Q4 2017 sales about $175.5 million

Tuesday, 9 Jan 2018 08:30am EST

Jan 9 (Reuters) - Globus Medical Inc ::GLOBUS MEDICAL REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR SALES RESULTS.SEES Q4 2017 SALES ABOUT $175.5 MILLION.SEES FY 2018 FULLY DILUTED NON-GAAP EARNINGS PER SHARE OF $1.50.SEES FY 2018 SALES $690 MILLION.Q4 SALES $175.5 MILLION VERSUS I/B/E/S VIEW $165.4 MILLION.

Stryker Expects 2017 Adj Net Earnings Per Diluted Share To Be Toward High End Of Previous Range Of $6.45-$6.50​

Tuesday, 9 Jan 2018 08:15am EST

Jan 9 (Reuters) - Stryker Corp ::STRYKER - EXPECT 2017 ADJUSTED NET EARNINGS PER DILUTED SHARE TO BE TOWARD HIGH END OF PREVIOUSLY ANNOUNCED RANGE OF $6.45 TO $6.50​.- EXPECT 2017 ADJUSTED NET EARNINGS PER DILUTED SHARE TO BE TOWARD HIGH END OF OUR PREVIOUSLY ANNOUNCED RANGE OF $6.45 TO $6.50​.- WITH RESPECT TO U.S. TAX REFORM, ANTICIPATE A MODEST HEADWIND FOR 2018.STRYKER - ‍FOREIGN CURRENCY EXCHANGE IMPACT ON NET SALES IN Q4 WAS POSITIVE OF ABOUT 1.2 PERCENT AND NOMINAL IN FULL YEAR​.REG-STRYKER PROVIDES 2017 PRELIMINARY NET SALES RESULTS.Q4 SALES $3.5 BILLION VERSUS I/B/E/S VIEW $3.39 BILLION.STRYKER SAYS PRELIMINARY ORTHOPAEDICS NET SALES OF $1.3 BILLION AS REPORTED IN Q4.- ‍PRELIMINARY DOMESTIC NET SALES OF $2.5 BILLION AND $9.1 BILLION INCREASED 9.3% AND 10.1% AS REPORTED IN Q4 AND FULL YEAR​.- ‍PRELIMINARY INTERNATIONAL NET SALES OF $1.0 BILLION AND $3.4 BILLION INCREASED 11.7% AND 9.4% AS REPORTED IN Q4 AND FULL YEAR​.Q4 REVENUE VIEW $3.39 BILLION -- THOMSON REUTERS I/B/E/S.FY2017 EARNINGS PER SHARE VIEW $6.47 -- THOMSON REUTERS I/B/E/S.

Ekso Bionics Q4 Revenue $2.5 Million

Tuesday, 9 Jan 2018 08:00am EST

Jan 9 (Reuters) - Ekso Bionics Holdings Inc ::EKSO BIONICS REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 REVENUE $2.5 MILLION.

Orthofix Announces Preliminary 2017 Fourth Quarter

Tuesday, 9 Jan 2018 08:00am EST

Jan 9 (Reuters) - Orthofix International Nv ::SAYS EXPECTS TO RECOGNIZE A ONE-TIME, NON-CASH TAX CHARGE OF $8 MILLION - $12 MILLION IN Q4 OF 2017.ORTHOFIX ANNOUNCES PRELIMINARY 2017 FOURTH QUARTER AND FULL YEAR NET SALES RESULTS.SEES FY 2018 SALES $450 MILLION TO $455 MILLION.Q4 SALES $117 MILLION VERSUS I/B/E/S VIEW $112.3 MILLION.

Hill-Rom Sees Adj EPS Above High-End Of Guidance Range For First Fiscal Quarter Of 2018

Tuesday, 9 Jan 2018 07:59am EST

Jan 9 (Reuters) - Hill-Rom Holdings Inc ::HILL-ROM - ‍BASED ON PRELIMINARY ASSESSMENT OF NEW U.S. TAX REFORM LEGISLATION, EXPECTS TO INCUR ONE-TIME NET BENEFIT OF ABOUT $50 MILLION TO $75 MILLION IN Q1​.HILL-ROM SAYS EXPECTS NEW U.S. TAX REGULATIONS TO HAVE POSITIVE IMPACT ON ADJUSTED EFFECTIVE TAX RATE, ADJUSTED EARNINGS, BEGINNING IN FISCAL Q1 2018.HILL-ROM ANNOUNCES PRELIMINARY FISCAL FIRST QUARTER FINANCIAL RESULTS AND COMMENTS ON EXPECTED IMPACT OF NEW U.S. TAX REFORM LEGISLATION.SEES Q1 2018 REVENUE ABOUT $670 MILLION.- SEES ADJUSTED EPS ABOVE HIGH-END OF GUIDANCE RANGE FOR FIRST FISCAL QUARTER OF 2018.HILL-ROM SAYS ‍EXPECTED ONE-TIME NET BENEFIT IN Q1 PRIMARILY RELATED TO REVALUATION OF NET DEFERRED TAX LIABILITIES.- FOR FISCAL 2018 AND FUTURE PERIODS, EXPECTS ADJUSTED EFFECTIVE TAX RATE BENEFIT OF ABOUT 500 BASIS POINTS.- SEES FISCAL 2018 Q1 ADJUSTED EARNINGS PER SHARE OF $0.77 TO $0.79.Q1 EARNINGS PER SHARE VIEW $0.79, REVENUE VIEW $656.5 MILLION -- THOMSON REUTERS I/B/E/S.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary